Genpact Limited (G) Stock Forecast
G analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.75 / 5 from 12 analysts
- Price target
- $42.64 average of analyst targets
- Upside to target
- +14.4% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $0.93
- 52-week range
- $27.50 – $48.50
G analyst ratings
12 analystsNumber of analysts at each rating.
G price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
G earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.04 | $1.04 | $1.06 | $0.97 | +7.6% | 11 |
| Current fiscal year (2026) | $4.12 | $4.08 | $4.15 | $3.65 | +12.9% | 12 |
| Next fiscal year (2027) | $4.51 | $4.40 | $4.60 | $4.12 | +9.5% | 12 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
G revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.38B | $1.37B | $1.38B | +6.5% | 11 |
| Current fiscal year (2026) | $5.44B | $5.43B | $5.44B | +7.0% | 12 |
| Next fiscal year (2027) | $5.82B | $5.78B | $5.87B | +7.1% | 12 |
G EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
G revenue: reported and forecast
G EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.05 | $1.04 | $1.04 | $1.04 | $1.04 | −0.3% | 4 up · 5 down |
| Current fiscal year (2026) | $4.07 | $4.12 | $4.12 | $4.12 | $4.12 | +1.2% | 10 up · 2 down |
| Next fiscal year (2027) | $4.48 | $4.51 | $4.51 | $4.51 | $4.51 | +0.7% | 9 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
G earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; G beat in 12 of 12.
What analysts expect from G
12 analysts cover Genpact; their consensus rating is buy (3.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $42.64, 14.4% above the latest close of $37.26. Analysts expect earnings of $4.12 per share for 2026, +12.9% from a year earlier. For 2027 the average estimate is $4.51 per share on revenue of $5.8 billion. Genpact beat the EPS estimate in 12 of the last 12 quarters.
Related: G income statement, G key metrics, G chart. See the G stock overview for the latest quote and news.
G forecast FAQ
What is Genpact's price target?
The average analyst price target for Genpact is $42.64, 14.4% above the latest close of $37.26.
Is Genpact a buy, hold or sell?
Of 12 analysts covering Genpact, 4 rate it a strong buy, 1 a buy, 7 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Genpact's EPS forecast?
Analysts forecast $4.12 per share for 2026 (range $4.08 to $4.15); for 2027 the estimate is $4.51.
What is Genpact's revenue forecast?
The average revenue estimate for 2026 is $5.4 billion, growth of 7.0%; for 2027 it is $5.8 billion.
When does Genpact report earnings?
Genpact is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $0.93.
Does Genpact usually beat earnings estimates?
Genpact reported EPS at or above the analyst estimate in 12 of the last 12 quarters.